Acadia Pharmaceuticals
|
14.99 |
|
0.13 |
0.87% |
-12.24% |
2025-04-15 |
Agios Pharmaceuticals
|
27.83 |
|
0.31 |
1.13% |
-3.37% |
2025-04-15 |
ALKERMES
|
27.81 |
|
0.27 |
0.98% |
15.78% |
2025-04-15 |
Alnylam Pharmaceuticals
|
230.71 |
|
-9.30 |
-3.87% |
57.25% |
2025-04-15 |
Amgen
|
295.44 |
|
1.74 |
0.59% |
11.24% |
2025-04-15 |
Biogen
|
116.98 |
|
-2.23 |
-1.87% |
-40.58% |
2025-04-15 |
BioMarin Pharmaceutical
|
60.00 |
|
0.33 |
0.55% |
-33.97% |
2025-04-15 |
Exelixis
|
36.53 |
|
0.79 |
2.21% |
60.08% |
2025-04-15 |
Incyte
|
58.46 |
|
-0.76 |
-1.28% |
9.76% |
2025-04-15 |
Ionis Pharmaceuticals
|
28.40 |
|
-0.28 |
-0.98% |
-31.63% |
2025-04-15 |
MacroGenics
|
1.26 |
|
-0.01 |
-0.79% |
-92.45% |
2025-04-15 |
Neurocrine Biosciences
|
96.22 |
|
1.33 |
1.40% |
-27.65% |
2025-04-15 |
Prothena
|
9.58 |
|
-0.36 |
-3.62% |
-55.11% |
2025-04-15 |
Ultragenyx Pharmaceutical
|
35.34 |
|
0.42 |
1.20% |
-16.47% |
2025-04-15 |
Regeneron Pharmaceuticals
|
557.94 |
|
-12.67 |
-2.22% |
-37.57% |
2025-04-15 |
Vertex Pharmaceuticals
|
500.35 |
|
4.44 |
0.90% |
26.92% |
2025-04-15 |